Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OFATUMUMAB vs OLANZAPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OFATUMUMAB vs OLANZAPINE: Safety Overview

Metric OFATUMUMAB OLANZAPINE
Total FAERS Reports 29,913 51,444
Deaths Reported 695 5,535
Death Rate 2.3% 10.8%
Hospitalizations 3,616 21,934
Average Patient Age 47.5 yrs 44.3 yrs
% Female Patients 74.9% 46.1%
FDA Approval Date N/A Apr 23, 2012
Manufacturer Novartis Pharmaceuticals Corporation REMEDYREPACK INC.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription